MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway.
Zhongyi ShenChengliang ZhangLishuai QuCuihua LuMingbing XiaoRunzhou NiJin-Xia LiuPublished in: Cancer cell international (2019)
MKP-4-mediated dephosphorylation of ERK1/2 might serve as a novel tumor-suppressive mechanism and provide a potential therapy for HCC.